http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1225174-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e7022e391363a3cf3486bf3859ce0a7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
filingDate 2000-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7994c08504a7c45741e077e8418a89d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdd5b28b00e2aff6157e27a9c911e0db
publicationDate 2002-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1225174-A1
titleOfInvention Anhydrous mirtazapine crystals and process for the production thereof
abstract Low-hygroscopic anhydrous mirtazapine crystals having a hygroscopicity of not more than 0.6% by weight when the crystals are stored in the air having a relative humidity of 75% at 25 DEG C under atmospheric pressure for 500 hours; a process for preparing the same; a crystal of a mirtazapine hydrate represented by the formula (I): <CHEM> wherein n is an integer of 1 to 5; and a process for preparing the same. According to the process of the present invention, stable anhydrous mirtazapine crystals having almost no hygroscopic property can be prepared by a convenient industrial process. In addition, since the anhydrous mirtazapine crystals of the present invention have excellent low hygroscopic property, they can be suitably used, for instance, as an antidepressant.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005051349-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10603272-B2
priorityDate 1999-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0062782-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228590516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9882242
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226689202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227547528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53476253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128988724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159156
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10221435

Total number of triples: 27.